肿瘤整形术联合背阔肌肌皮瓣在中-小型外侧象限乳腺癌保乳重建中的应用体会

doi:10.3969/j.issn.1009-976X.2015.01.005

摘要/Abstract

摘要：

【摘要】〓目的〓探讨肿瘤整形技术联合背阔肌肌皮瓣在中-小型乳房外侧象限乳腺癌保乳重建中的美容效果。方法〓选择肿瘤位于乳房外侧象限的14例中-小型乳房乳腺癌患者,肿瘤距离乳头乳晕大于3 cm,保乳术后缺损体积超过20%的病人,采取肿瘤整形技术联合部分背阔肌肌皮瓣修复缺损。结果〓肿瘤直径中位大小3.2 cm(2.2~8.1 cm),切除中位体积为62.0 g(50.0~100.0 g),中位随访17(3.0~42.0)月,术后美容效果14例患者11例(79%)为优,3例(21%)为良,随访期间无1例复发及转移。结论〓肿瘤整形技术联合部分背阔肌皮瓣是一种安全有效修复保乳术后缺损的方法,特别适合肿瘤位于外侧象限,术后缺损体积超过20%的中-小型乳房。

关键词: 乳腺肿瘤, 乳房成形术, 乳房重建, 背阔肌肌皮瓣

Abstract:

【Abstract】〓Objective〓To investigate the aesthetic effect of oncoplastic reconstruction with latissimus dorsi myocutaneous flap after the lateral quadrant tumor resectionin small to moderate-sized breasts. Methods〓We enrolled 14 patients with invasive breast cancer located in the lateral quadrant of the breast, which were located more than 3 cm apart from the nipple, after breast completing a quadrantectomy defect volume of more than 20% patients, repair the defect with oncoplastic reconstruction with latissimusdorsimyocutaneous flap. Results〓Median tumor size was 3.2 cm (ranged, 2.2-8.1 cm) and median resected volume was 62.0 g (range, 50.0-100.0 g). With a mean follow-up of 17.0 months (range, 3.0~42.0 months), cosmetic outcomes were good (79%) to fair (21%), and there was no local or systemic recurrence during the short term follow-up period. Conclusion〓This type of oncoplastic reconstruction with latissimus dorsi-mysocutaneous flap reconstruction is an oncologically safe and a cosmetically sound procedure,especially for cosmetic treatment of small to medium-sized breasts after lateral quadrant tumor resection, defect volume of more than 20% patients.

Key words: Mammoplasty, Breast neoplasms, Latissimus dorsi myocutaneous flap, Breast reconstruction

中图分类号:

胡小戊章乐虹夏婷曹腾飞贾海霞. 肿瘤整形术联合背阔肌肌皮瓣在中-小型外侧象限乳腺癌保乳重建中的应用体会[J]. 岭南现代临床外科, 2015, 15(01): 22-26.

Hu Xiaowu, Zhang Lehong, Xia Ting, Cao Tengfei, Jia Haixia. Oncoplastic reconstruction combined with latissimus dorsi myocutaneous flap after lateral quadrant tumor resection in small to moderate-sized breasts[J]. Lingnan Modern Clinics in Surgery, 2015, 15(01): 22-26.

参考文献

1. Bulstrode NW, Shrotria S. Prediction of cosmetic outcome following conservative breast surgery using breast volume measurements. Breast 2001;10:124-6.
2. Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 2010;17:1375-91.
3.Kim, J.Yoo, J.Lee, J.Chang, et al. Oncoplastic reconstruction with superior based lateral breast rotation flap after lower quadrant tumor resection. Gland Surg 2013.;(3):163-9.
4. O. Abe, R. Abe, K. Asaishi et al., “Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials,” The New England Journal of Medicine, 1995,22(333) 1444–1455.
5.G. Y. Locker, J. R. Sainsbury, and J. Cuzick, “Breast surgery in the ’Arimidex, Tamoxifen Alone or in Combination’ (ATAC) trial: american women are more likely than women from the United Kingdom to undergo mastectomy,” Cancer, 2004，4(101) 735–740.
6. R. A. Cochrane, P. Valasiadou, A. R. M. Wilson, S. K. Al- Ghazal, and R. D. Macmillan, “Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised,” British Journal of Surgery,2003,12(90) 1505–1509 .
7. Baildam AD. Oncoplastic surgery of the breast. Br J Surg 2002;89:532-33.
8. AsgeirssonKS,RasheedT,McCulleySJ,etal.Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol 2005;31:817-23.
9. Quinn McGlothin TD. Breast surgery as a specialized practice. Am J Surg 2005;190:264-68.
10. Brédart A, Petit JY. Partial mastectomy: a balance between oncology and aesthetics? Lancet Oncol 2005;6:130.
11. McCulley SJ, Macmillan RD. Planning and use of therapeutic mammo- plasty: Nottingham approach. Br J Plast Surg 2005;58:889-901.
12. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, et al. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conserva- tion therapy. Plast Reconstr Surg 2007;120:1755-68.
13. Clough KB, Ihrai T, Oden S, Kaufman G, Massey E, Nos C. Oncoplastic surgery for breast cancer based on tumour location and a quadrant- per-quadrant atlas. Br J Surg 2012;99:1389-95.
14.Almasad JK, Salah B. Breast reconstruction by local flaps after conserv- ing surgery for breast cancer: an added asset to oncoplastic techniques. Breast J 2008;14:340-4. ?
15. Yang, J. D.Kim, M. C.Lee, J. W. Usefulness of Oncoplastic Volume Replacement Techniques after Breast Conserving Surgery in Small to Moderate-sized Breasts. Arch Plast Surg2012.39(5)489-96.
16. R. Masetti, P. G. Pirulli, S. Magno, G. Franceschini, F. Chiesa, and A. Antinori, “Oncoplastic techniques in the conservative surgical treatment of breast cancer,” Breast Cancer,2000，4(7) 276–280.
17. O. Anderson, R. Masetti, and M. J. Silverstein, “Oncoplastic approaches to partial mastectomy: an overview of volume- displacement techniques,” The Lancet Oncology2005, 3(6) 145–157.
18.E.Wagner,P.Schrenk,G.M.Huemer,A.Sir,M.Schreiner,and W.Wayand, “Central quadrantectomy with resection of the nipple-areola complex compared with mastectomy in patients with retroareolar breast cancer,” The Breast Journal 2007,6(13) 557–563.
19.Baudet J. Successful clinical tranfer of two free thoracodorsal axillary flaps [J] Plast Reconstr Surg,1976,58:680- 684.
20.Schwabegger AH,Harpf C,Rainer C.Muscle -sparing latissimus dorsimyocutaneous flap with maintenance of muscle innervation, function,and aesthetic appearance of the donor site [J].Plast Reconstr Surg,2003,111:1407- 1411.
21.Rietjens M，Urban CA,Rey PC,et al.Long-term oncological results of breast conservative treatment with oncoplastic surgery.Breast,2007,16:389-95.

[1]	武霄勇, 闫学敏, 张佳谊, 文锦旭, 祝嘉, 王跃欣. 乳腺腺样囊性癌两例并文献复习[J]. 岭南现代临床外科, 2023, 23(04): 343-346.
[2]	胡小戊, 章乐虹, 何咏, 陈欣欣, 夏婷, 曹腾飞, 贾海霞. 术中定向放疗推量照射在乳腺癌保乳术中临床应用研究[J]. 岭南现代临床外科, 2020, 20(06): 689-693.
[3]	陈继鑫, 孔恒. 多模态乳腺肿瘤图像特征提取与分级诊断的研究进展[J]. 岭南现代临床外科, 2020, 20(06): 789-795.
[4]	甄乐锋，陈晓明，黄涛，王金重，文达辉. 麦默通旋切活检和金属导丝定位活检在临床触诊阴性乳腺病灶活检中的应用对比[J]. 岭南现代临床外科, 2019, 19(03): 289-292.
[5]	丁柱良吴智勇. 乳腺癌孤立性局部区域复发的诊断和治疗[J]. 岭南现代临床外科, 2017, 17(03): 371-375.
[6]	张晓叶一峰. 软组织扩张器在乳腺癌假体乳房重建术中的应用[J]. 岭南现代临床外科, 2017, 17(02): 194-197.
[7]	杨丽美姚和瑞刘玉洁 . 抑制 miR?223 表达促进巨噬细胞的 M2 型激活[J]. 岭南现代临床外科, 2017, 17(01): 5-10.
[8]	曹腾飞唐甜许清雅江海瀚贾海霞章乐虹 . 1~2 枚前哨淋巴结阳性乳腺癌患者中非前哨淋巴结转移的影响因素分析[J]. 岭南现代临床外科, 2017, 17(01): 11-14.
[9]	高进唐炜叶熹罡陈伦潘凌霄张晓申郑文博. 趋化因子配体18在乳腺癌组织中的表达与预后分析[J]. 岭南现代临床外科, 2015, 15(06): 664-667.
[10]	文丽君. 乳腺癌患者术后延伸护理服务的应用[J]. 岭南现代临床外科, 2014, 14(05): 609-611.
[11]	徐泰李顺荣赖烨钤黄杰文丘冬琴范苑林李璐. 浅谈乳腺肿物麦默通旋切术的操作经验[J]. 岭南现代临床外科, 2014, 14(03): 291-293.
[12]	连臻强张安秦韩晓蓉张嫣郜红艺王颀. X线检查阴性乳腺导管原位癌的临床病理特点[J]. 岭南现代临床外科, 2014, 14(01): 83-85.
[13]	杨剑敏王颀于海静张安秦李文萍许娟. 乳腺癌全乳切除术后I/II期假体植入重建乳房[J]. 岭南现代临床外科, 2013, 13(04): 295-297.
[14]	许娟朱彩霞杨剑敏连臻强陈中扬王颀. pT_1a和pT_1b乳腺癌130例临床病理特征分析[J]. 岭南现代临床外科, 2013, 13(03): 177-180.